Stem Cells Show Durable Benefit For Perianal Fistulas – Gastroenterology & Endoscopy News
|
Stem Cells Show Durable Benefit For Perianal Fistulas
Gastroenterology & Endoscopy News Orlando, Fla.—In a double-blind, phase 3 trial in patients with Crohn's disease, stem cell treatment of perianal fistulas provided even better outcomes at 52 weeks than originally reported at 26 weeks. In Europe, where the trial was conducted … |
